Literature DB >> 7050957

Detection and isolation of fetal cells from maternal blood using the flourescence-activated cell sorter (FACS).

G M Iverson, D W Bianchi, H M Cann, L A Herzenberg.   

Abstract

The presence of fetal cells in the maternal circulation during pregnancy has been suggested by repeated observations of small numbers of cells containing Y chromatin or a Y chromosome in the blood of pregnant women. With the fluorescence-activated cell sorter (FACS), we have used antibodies to a paternal cell surface (HLA) antigen, not present in the mother, to select fetal cells from the lymphocyte fractions of a series of maternal blood samples, collected as early as 15 weeks of gestation. These sorted cells have been examined for a second paternal genetic marker, Y chromatin. Y chromatin-containing cells were found among the sorted cells from prenatal maternal blood specimens in 8 pregnancies subsequently producing male infants whose lymphocytes reacted with the same antibodies to paternal antigen used for sorting with the FACS. In each of 17 pregnancies resulting in male infants who failed to inherit the antigen detected by the antibodies used for cell sorting, Y chromatin-containing cells were not found prenatally. The use of two paternal genetic markers, a cell surface antigen and nuclear Y chromatin, to identify fetal cells in maternal blood permits us to conclude that these cells are present in the mother's circulation, as early as 15 weeks gestation. Further development of the techniques reported here could lead to widespread screening of maternal blood samples during pregnancy for detection of fetal genetic abnormalities.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7050957     DOI: 10.1002/pd.1970010111

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  16 in total

1.  Extravillus dividing fetal cells at CVS: evidence of their erythroblastic origin.

Authors:  G Terzoli; R Cartolano; F Rossella; A Cantù-Rajnoldi; B Brambati; M Fraccaro; G Simoni
Journal:  J Med Genet       Date:  1992-10       Impact factor: 6.318

2.  P63 expression levels in side population and low light scattering ocular surface epithelial cells.

Authors:  Seth P Epstein; J Mario Wolosin; Penny A Asbell
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 3.  A historical and practical review of first trimester aneuploidy screening.

Authors:  Melissa L Russo; Karin J Blakemore
Journal:  Semin Fetal Neonatal Med       Date:  2013-12-14       Impact factor: 3.926

4.  Fetal cells in the maternal circulation: detection by direct AFP-immunofluorescence.

Authors:  A Kulozik; I H Pawlowitzki
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

Review 5.  Recent advances of genomic testing in perinatal medicine.

Authors:  David G Peters; Svetlana A Yatsenko; Urvashi Surti; Aleksandar Rajkovic
Journal:  Semin Perinatol       Date:  2014-11-28       Impact factor: 3.300

6.  A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women.

Authors:  R Huang; T A Barber; M A Schmidt; R G Tompkins; M Toner; D W Bianchi; R Kapur; W L Flejter
Journal:  Prenat Diagn       Date:  2008-10       Impact factor: 3.050

7.  Isolation of fetal DNA from nucleated erythrocytes in maternal blood.

Authors:  D W Bianchi; A F Flint; M F Pizzimenti; J H Knoll; S A Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Fetal nucleated cells in maternal peripheral blood: frequency and relationship to gestational age.

Authors:  H Hamada; T Arinami; T Kubo; H Hamaguchi; H Iwasaki
Journal:  Hum Genet       Date:  1993-06       Impact factor: 4.132

Review 9.  Cell migration from baby to mother.

Authors:  Gavin S Dawe; Xiao Wei Tan; Zhi-Cheng Xiao
Journal:  Cell Adh Migr       Date:  2007-01-28       Impact factor: 3.405

10.  Human trophoblast cell-surface antigens defined by monoclonal antibodies.

Authors:  M Lipinski; D R Parks; R V Rouse; L A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.